269 related articles for article (PubMed ID: 36014536)
61. Update on the development of TGR5 agonists for human diseases.
Jin W; Zheng M; Chen Y; Xiong H
Eur J Med Chem; 2024 May; 271():116462. PubMed ID: 38691888
[TBL] [Abstract][Full Text] [Related]
62. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
63. TGR5: a novel target for weight maintenance and glucose metabolism.
Chen X; Lou G; Meng Z; Huang W
Exp Diabetes Res; 2011; 2011():853501. PubMed ID: 21754919
[TBL] [Abstract][Full Text] [Related]
64. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
65. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
66. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.
Carino A; Graziosi L; D'Amore C; Cipriani S; Marchianò S; Marino E; Zampella A; Rende M; Mosci P; Distrutti E; Donini A; Fiorucci S
Oncotarget; 2016 Sep; 7(38):61021-61035. PubMed ID: 27409173
[TBL] [Abstract][Full Text] [Related]
67. Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis.
Zhang H; Xu H; Zhang C; Tang Q; Bi F
Cell Death Discov; 2021 Aug; 7(1):207. PubMed ID: 34365464
[TBL] [Abstract][Full Text] [Related]
68. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
[TBL] [Abstract][Full Text] [Related]
69. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
[TBL] [Abstract][Full Text] [Related]
70. Role of TGR5 (GPBAR1) in Liver Disease.
Keitel V; Häussinger D
Semin Liver Dis; 2018 Nov; 38(4):333-339. PubMed ID: 30357770
[TBL] [Abstract][Full Text] [Related]
71. Bile acid signaling in renal water regulation.
Li S; Li C; Wang W
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
[TBL] [Abstract][Full Text] [Related]
72. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice.
Thibaut MM; Gillard J; Dolly A; Roumain M; Leclercq IA; Delzenne NM; Muccioli GG; Bindels LB
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945009
[TBL] [Abstract][Full Text] [Related]
73. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
Guo C; Qi H; Yu Y; Zhang Q; Su J; Yu D; Huang W; Chen WD; Wang YD
Front Pharmacol; 2015; 6():287. PubMed ID: 26696888
[TBL] [Abstract][Full Text] [Related]
74. Perspective: TGR5 (Gpbar-1) in liver physiology and disease.
Keitel V; Häussinger D
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):412-9. PubMed ID: 22521118
[TBL] [Abstract][Full Text] [Related]
75. Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor.
Iguchi Y; Yamaguchi M; Sato H; Kihira K; Nishimaki-Mogami T; Une M
J Lipid Res; 2010 Jun; 51(6):1432-41. PubMed ID: 20023205
[TBL] [Abstract][Full Text] [Related]
76. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
[TBL] [Abstract][Full Text] [Related]
77. Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage.
Reich M; Klindt C; Deutschmann K; Spomer L; Häussinger D; Keitel V
Dig Dis; 2017; 35(3):235-240. PubMed ID: 28249265
[TBL] [Abstract][Full Text] [Related]
78. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.
Spatz M; Ciocan D; Merlen G; Rainteau D; Humbert L; Gomes-Rochette N; Hugot C; Trainel N; Mercier-Nomé F; Domenichini S; Puchois V; Wrzosek L; Ferrere G; Tordjmann T; Perlemuter G; Cassard AM
JHEP Rep; 2021 Apr; 3(2):100230. PubMed ID: 33665587
[TBL] [Abstract][Full Text] [Related]
79. Smooth muscle contractile responses to bile acids in mouse ileum require TGR5 but not ASBT.
Chang DS; Soni KG; Preidis GA
Front Neurol; 2024; 15():1334319. PubMed ID: 38721114
[TBL] [Abstract][Full Text] [Related]
80. The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice.
Sasaki T; Kuboyama A; Mita M; Murata S; Shimizu M; Inoue J; Mori K; Sato R
J Biol Chem; 2018 Jun; 293(26):10322-10332. PubMed ID: 29773650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
